Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewPomalidomide 4'-alkylC3-azide
Description: Cereblon ligand with alkyl linker and terminal azide for onward chemistry
Chemical Name: 4-[(3-Azidopropyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione
Purity: ≥95% (HPLC)
Biological Activity for Pomalidomide 4'-alkylC3-azide
Pomalidomide 4'-alkylC3-azide is a functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC3 linker with terminal azide ready for conjugation to a target protein ligand. Part of a range of functionalized tool molecules for PROTAC R&D.
Please contact us for SD files of our available Degrader Building Blocks.
PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
Usage Guidelines for Pomalidomide 4'-alkylC3-azide
This product is provided for use in onward chemistry. Suitable solvents can be used.
Technical Data for Pomalidomide 4'-alkylC3-azide
| M. Wt | 356.34 |
| Formula | C16H16N6O4 |
| Storage | Store at -20°C |
| Purity | ≥95% (HPLC) |
| CAS Number | 2357108-05-3 |
| InChI Key | XYBSIBZAOLUERZ-UHFFFAOYSA-N |
| Smiles | [N-]=[N+]=NCCCNC1=C2C(N(C(C2=CC=C1)=O)C3CCC(NC3=O)=O)=O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Product Datasheets for Pomalidomide 4'-alkylC3-azide
References for Pomalidomide 4'-alkylC3-azide
References are publications that support the biological activity of the product.
If you know of a relevant reference for Pomalidomide 4'-alkylC3-azide, please let us know.
View Related Products by Target
Keywords: Pomalidomide 4'-alkylC3-azide, Pomalidomide 4'-alkylC3-azide supplier, PROTAC, component, cereblon, E3, ubiquitin, ligase, AlkylC3, linker, conjugate, building, block, ligands, targeted, targeting, protein, degradation, TPD, Cereblon, Ligands, Plus, Linkers, 7440, Tocris Bioscience
Citations for Pomalidomide 4'-alkylC3-azide
Citations are publications that use Tocris products.
Currently there are no citations for Pomalidomide 4'-alkylC3-azide. Do you know of a great paper that uses Pomalidomide 4'-alkylC3-azide from Tocris? Please let us know.
Reviews for Pomalidomide 4'-alkylC3-azide
There are currently no reviews for this product. Be the first to review Pomalidomide 4'-alkylC3-azide and earn rewards!
Have you used Pomalidomide 4'-alkylC3-azide?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
TPD and Induced Proximity Research Product GuideUpdated
This brochure highlights the tools and services available from Bio-Techne to support your Targeted Protein Degradation and Induced Proximity research, including:
- Active Degraders
- TAG Degradation Platform
- Degrader Building Blocks
- Assays for Protein Degradation
- Induced Proximity Tools
Targeted Protein Degradation Poster
Degraders (e.g. PROTACs) are bifunctional small molecules, that harness the Ubiquitin Proteasome System (UPS) to selectively degrade target proteins within cells. They consist of three covalently linked components: an E3 ubiquitin ligase ligand, a linker and a ligand for the target protein of interest. Authored in-house, this poster outlines the generation of a toolbox of building blocks for the development of Degraders. The characteristics and selection of each of these components are discussed. Presented at EFMC 2018, Ljubljana, Slovenia